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Nuclear protein in testis midline carcinoma
Hilar/endobronchialNuclear protein of the testis (NUT)midline carcinoma (NMC) is a rare aggressive tumor described in themidline
in the chest and head and neck. Initially reported in younger individuals, it has subsequently been shown to have
a wider age distribution. The deﬁning feature of these tumors is its association with BRD-NUT rearrangements.
Occasionally NMC has been observed in a non-midline location. This case report describes an unusual rapidly
progressingnon-midline hilar/endobronchial location of anNMC in a 34-year-oldman. The clinical and histologic
featureswere that of an undifferentiated neoplasm concerning for a small cell carcinoma or a lymphoma. A broad
panel of immunohistochemical markers for carcinoma, lymphoma andmelanomawere negative which led us to
suspect a diagnosis of NMC. A positive immunostainingwith p63 and NUT protein antigen conﬁrmed the diagno-
sis. The p63 positivity and cytokeratin negativity suggest a primitive/precursor squamous cell derivation.
© The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
NUT (nuclear protein in testis)midline carcinoma (NMC) is a recent-
ly described aggressive poorly differentiated subtype of squamous cell
carcinoma [1–9]. It is one of the few solid tumors with a deﬁning trans-
location in absence of complex cytogenetic changes commonly associat-
ed with squamous cell carcinoma. The deﬁning feature of this tumor is
the rearrangement of the NUT gene on chromosome 15. The partner
gene in most instances is the BRD4 gene on chromosome 19 resulting
in a t(15;19) translocation. In some cases, the partner gene is BRD3
while in other cases it remains unresolved [1]. The diagnosis in most
cases is elusive because of its rarity and its ability to mimic common
neoplasms such as small cell carcinoma and lymphoma. Its early recog-
nition and consideration by a pathologist are imperative since these are
aggressive lesions with a fatal outcome in most instances. This case re-
port describes a very unusual NMC in hilar/endobronchial location
with a rapid fatal clinical course that we recently encountered in our
consult service.2. Materials and methods
A 34-year-old man in prior good health presented with sudden onset
of exertional dyspnea and interscapular pain of 1-month duration not1 210 567 2478.
un@ipc-hub.com (S. Mamun),
is is an open access article under t
ar/endobronchial NUT midlinrelieved by acetaminophen. He developed nonproductive cough without
high fever and chills 1 week before hospitalization. A chest X-ray at the
urgent care center 2 days before admission revealed right lower lobe
pneumonia for which he was treated with broad-spectrum antibiotics.
The patient had been in good health all his life and denied any child-
hood or adult illnesses. There was no family history of chronic pulmo-
nary or cardiac illness and no history of cancer. He did not use tobacco
products, rarely drank alcohol and denied use of recreational drugs
and risk factors for HIV. He did not have any pets and had not traveled
outside of Texas in the recent past. A computed tomography scan of
chest (Fig. 1A and B) with administration of contrast documented a
large 9 cm mass involving the right main-stem bronchus with post-
obstructive pneumonia in right lower lobe and right pleural effusion.
This mass encased the right pulmonary artery and vein as well as the
esophagus circumferentially and caused compression of superior vena
cava. Therewas bulkymediastinal lymphadenopathy. During bronchos-
copy it was noted that the right main-stem bronchus was closed past
the level of right upper lobe bronchus. He had an endobronchial lesion
in this area with splaying of the carina consistent with lymphadenopa-
thy. Transbronchial lung biopsy and bronchoalveolar ﬂuid were obtain-
ed and sent to pathology.
The clinical differential diagnosis considered was primary lung can-
cer, lymphoma and sarcoma. Following this, staging work up was initi-
ated that demonstrated a probable 2.1 cm left adrenal mass, malignant
retroperitoneal lymphadenopathy and probable metastatic lesion at
lumbar 5 vertebra. Additionally, a magnetic resonance imaging of his
brain after administration of gadolinium revealed metastatic lesions in-
volving the right posterior frontal and anterior parietal region. The le-
sion involved the bony cranium and scalp with minimal compressionhe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Fig. 1. A: Coronal chest CT scan showing the right hilar mass (arrows) and dense right
lower lobe consolidation. B: Horizontal chest CT scan showing the right hilar mass.
Fig. 2. A: Cell-block demonstrating a poorly differentiated neoplasm with non-cohesive
small blue round cells in sheets (H&E, 200×). B: p63 immunostainwith positively staining
tumor cells and surface non-neoplastic epithelium (200×). C: Nuclear protein in Testis
(NUT) immunostain with positive staining in tumor cells. Note the overlying epithelium
is negative (200×).
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ment, the patient continued to develop progressivelyworsening hypox-
emia, tachypnea and respiratory insufﬁciency. No speciﬁc therapy
directed at his presumed malignancy could be initiated due to diagnos-
tic uncertainty. A repeat computed tomography scan of the chest just
4 days later demonstrated complete consolidation and/or collapse of
right upper and lower lobes and large right pleural effusion. These ﬁnd-
ings were signiﬁcantly worse compared to the initial computed tomog-
raphy done on the day of admission. His overall prognosis was felt to be
grim by the treating physicians and his family opted against chemother-
apy. Hewas terminally extubated on hospital day 10 and expired short-
ly thereafter.
3. Pathology
The cytology material was referred for consultation to our hospital.
The smears were cellular with non-cohesive sheets of small round
cells. There was nuclear overlapping and cells had distinct cell borders
with a high nuclear: cytoplasmic ratio. Focal rosettingwas seen. The nu-
clei were characterized by dispersed chromatin with conspicuous small
1–2 nucleoli. H&E stained sections of the cell-block (Fig. 2A) showed
similarﬁndings of small round blue cells underlying the respiratorymu-
cosa. The cells were in sheets with round to oval small hyperchromatic
nuclei with conspicuous nucleoli, lacked molding, and had scant
amphophilic cytoplasm. The morphological differential diagnosis was
that of undifferentiated small round blue cell tumor which included
lymphoma, melanoma and undifferentiated carcinoma. The non-
cohesive pattern of cells with lack of molding and occasional nucleoli
was features against a small cell carcinoma. The cells were negativePlease cite this article as: D. Sirohi, et al., Hilar/endobronchial NUT midlin
dx.doi.org/10.1016/j.ehpc.2015.06.004for markers for lymphoma and granulocytic sarcoma including
CD45RB (leukocyte common antigen), CD20, CD3, CD25, CD30, kappa,
lambda, MUM-1, CD43, terminal deoxynucleotidyl transferase (TDT),
CD68, myeloperoxidase and lysozyme.Markers for small cell carcinoma
(CD56, synaptophysin and chromogranin) andmelanoma (S-100)were
also negative. Additionally, all epithelial markers CAM 5.2, cytokeratins
5/6, 7 and 20were negative. The tumorwas highly proliferative on a Ki-
67 immunostain.
The cellswere strongly immunoreactive for p63 (Fig. 2B). Basedon the
p63 positivity and the rapid clinical course the possibility of NUT midline
carcinoma (NMC) was considered. The case was sent for NUT-antigen
(Fig. 2C) immunostain (Propath, Dallas) which was positive in majority
of the tumor nuclei in a speckled pattern, conﬁrming the diagnosis.
4. Discussion
This case report illustrates a highly unusual hilar/endobronchial pre-
sentation of an NMC. Usually described inmidline in the chest, head ande carcinoma: A case report, Human Path Case Reports (2016), http://
Table 1
Comparison of the 3 previously reported hilar NMCs with the present case
Case 1 Case 2 Case 3 Case 4
Reference Tanaka et al. [2] Tanaka et al. [2] Parikh et al. [3] Present case
Age 14 years 7 years 36 years 34 years
Ethnicity Japanese Japanese White White
Sex Male Female Male Male
Imaging Mass in the left lower lobe of
lung (7 cm)
Mass in the left lower lobe of
lung
Right hilar mass, 6 cm Right main-stem bronchus, 9 cm
Histopathology Sheets of round-to-oval nuclei
with conspicuous nucleoli,
relatively ﬁne chromatin and
slightly basophilic cytoplasm
Nests of overtly epithelial
tumor cells with overt
squamous differentiation in
some nests with abrupt
transition
Large epithelioid cells with small amount
of cytoplasm, prominent nucleoli and
extensive necrosis
Non-cohesive cells in sheets with
round to oval small hyperchromatic
overlapping, nuclei, scant amphophilic
cytoplasm and conspicuous nucleoli
Immunohistochemistry
(positive)
p63 and NUT. CK5, CK8, CK
1/5/10/14 (focal). TTF-1
p63 and NUT. CK5, CK7, CK8,
CK19,, CK1/5/10/14
NUT p63 and NUT
Immunohistochemistry
(negative)
CK7, CK19, CK20, muscle actin,
desmin, smooth muscle actin,
neuroﬁlament, synaptophysin,
chromogranin A, CD5, CD34,
CD99, WT1
CK20, TTF-1, muscle actin,
desmin, smooth muscle actin,
neuroﬁlament, synaptophysin,
chromogranin A, CD5, CD34,
CD99, WT1
AE1/3, CK7, OSCAR, CAM 5,2, EMA, CD45,
S-100, CD117, TTF-1, PLAP, Octamer
binding transcription factor 4, CD31,
CD34, friend leukemia integration-1
transcription factor-1
CD45RB, CD20, CD3, CD25, CD30,
Kappa, Lambda, MUM-1, CD43, TDT,
CD68, Myeloperoxidase, Lysozyme,
synaptophysin, chromogranin A, CD56,
CAM 5.2, Cytokeratins 5/6, CK7, CK20,
S-100








Molecular ﬁndings BRD4-NUT fusion gene (PCR) BRD4-NUT fusion gene (PCR) BRD4-NUT fusion gene (FISH)
Survival 1 year after diagnosis 4 months after diagnosis (?) 3–4 weeks of onset of symptoms 4 weeks after onset of symptoms
CAM 5.2, cell adhesionmolecule 5.2; CD, cluster of differentiation; CK, cytokeratin; EMA, epithelial membrane antigen; FISH, ﬂuorescent in-situ hybridization; NUT, nuclear protein of the
testis; PLAP, placental alkaline phosphatase; PCR, polymerase chain reaction; TDT, terminal deoxynucleotidyl transferase; TTF-1, thyroid transcription factor-1.
3D. Sirohi et al. / Human Pathology: Case Reports xxx (2016) xxx–xxxneck, there have been only 3 prior reports of a pulmonary hilar presen-
tation [2,3; Table 1]. All 4 patients, including the current patient were
young with the age range of 7–36 years. Two were Japanese and 2
were white. Two patients presented with a mass in the left lower lobe
while one with a right hilar mass. Our patient had an endobronchial
component in addition to hilar involvement with complete collapse of
the right lung. Histopathologically two patients had overtly epithelial
features with one having bland abrupt keratinization. The other 2 had
discohesive cells mimicking a lymphoma. NMCs have been thought to
be poorly differentiated primitive subtypes of squamous cell carcinoma
based on the p63 positivity and ultrastructural ﬁndings [2]. NMCs have
been shown to have incomplete intercellular junctions and sparse or-
ganelles. After chemotherapy, features of differentiation like basal lam-
ina and more developed intercellular junctions and intracellular
organelles were demonstrated.
NMC is a diagnostic challenge to pathologists because it can mimic
both a small cell malignancy as well as a large cell malignancy. It may
alsomimic a lymphoma as well as a carcinoma. In our case the cytology
was most helpful in eliminating a small cell carcinoma and lymphoma.
Our case was also a challenge to the clinicians because both age and
bulky lymphadenopathy supported a diagnosis of lymphoma, whereas
as the presence of metastases to the adrenal gland, brain and bone sup-
ported a lung carcinoma. The presence of p63 in the absence of a posi-
tive high and low molecular weight cytokeratin was helpful in
eliminating a garden-variety squamous cell carcinoma.
These carcinomas are associated with a dismal prognosis with ame-
dian survival of 6.7 months and a greater than 80% likelihood of death
within the ﬁrst year of diagnosis [6]. Various therapeutic modalities
have been tried, but the most promising relate to the bromodomain
containing NUT fusion proteins that result in aberrant histone acetyla-
tion and blocking the differentiation. Consequently direct acting inhibi-
tors of BRD3 and BRD4 bromodomains like JQ1 are potentials for
targeted therapy. These have been shown to promote differentiation
in tumor cells in research studies [6]. Two phase 1 trials with BET
(bromodomain and extra terminal) inhibitors for NMC are currently
open [10].
NUTmidline carcinomas have clearly been overlooked in thepast. To
address this issue, Evans et al. examined NUT protein expressionPlease cite this article as: D. Sirohi, et al., Hilar/endobronchial NUT midlin
dx.doi.org/10.1016/j.ehpc.2015.06.004retrospectively in 114 cases of poorly differentiated carcinomas or un-
classiﬁed mediastinal malignancies using a clinically validated NUT-
speciﬁc monoclonal antibody [11]. Four of 114 (3.5%) cases showed nu-
clear NUT expression thatwas conﬁrmed byﬂuorescence in situ hybrid-
ization in 3 of these cases. These cases were initially diagnosed as
undifferentiated epithelioid or round cell malignant neoplasm and one
case with focal squamous differentiation was reported as poorly differ-
entiated squamous carcinoma of probable thymic origin. NMC should
be considered in the differential diagnosis of any poorly differentiated
epithelioid mediastinal tumor, regardless of age.
5. Conclusion
This case report presents a rare hilar/endobronchial occurrence of
NMC in a young adult with a rapid and fatal clinical outcome. A high
index of suspicion and awareness of NMC when facing undifferentiated
neoplasms of the chest, head and neck and non-midline location is im-
perative in establishing a timely diagnosis.
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